People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biofrontera Inc. | — | Pharmaceuticals | Series A | $58.4M | $36.3M | 2024 |
Hermann Luebbert at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hermann Luebbert on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Beth J. Hoffman | 1 | 1 |
| John J. Borer III | 1 | 1 |
| Eugene Frederick Leffler, III | 1 | 1 |
| Heikki J. Lanckriet | 1 | 1 |
| Kevin D. Weber | 1 | 1 |
| John J III Borer | 1 | 1 |
| Hermann J Luebbert | 1 | 1 |
| Erica F Gates | 1 | 1 |
| Erica L Monaco | 1 | 1 |
| Eugene Frederick Leffler | 1 | 1 |
| Loretta M Wedge | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.